A bitter pill for pharmacists: No provider status in Senate’s coronavirus relief package

Maia Anderson –
Wednesday, July 29th, 2020
Print|Email.

” The final coronavirus stimulus legislation throughout this election year provides our shining opportunity to achieve a targeted variation of provider status. Together with our members, APhA wishes to unleash the full capacity of pharmacists contributions for screening and immunization during COVID-19,” APhA CEO Scott Knoer, PharmD, said..

More articles on pharmacy: Trumps meeting with pharma execs canceled after drug lobbies refuse to reveal upAstraZeneca to pay Emergent $174M to expand production of COVID-19 vaccine candidateGeneric drug trade group loses quote to obstruct California pay-to-delay law.

APhA produced a petition prompting Congress to consist of provider status for pharmacists in its next legal package.

The organization argues that designating pharmacists as suppliers under Medicare Part B would have permitted Congress to dramatically broaden COVID-19 screening and immunization efforts..

The American Pharmacists Association launched a declaration July 28 expressing its dissatisfaction that the Senates $1 trillion COVID-19 stimulus package announced July 27– does not consist of language designating pharmacists as suppliers for COVID-19 screening and immunization..

© Copyright ASC COMMUNICATIONS 2020. Intrigued in LINKING to or REPRINTING this material? View our policies by click on this link.